Magnesium in PDB 5lkg: Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl)
Protein crystallography data
The structure of Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl), PDB code: 5lkg
was solved by
B.K.Singh,
V.Morozov,
G.S.Hansman,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.30 /
1.51
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
76.200,
86.680,
97.060,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.3 /
20.4
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl)
(pdb code 5lkg). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl), PDB code: 5lkg:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 5lkg
Go back to
Magnesium Binding Sites List in 5lkg
Magnesium binding site 1 out
of 2 in the Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg604
b:20.6
occ:1.00
|
H
|
A:LEU229
|
2.3
|
23.8
|
1.0
|
H
|
A:PHE517
|
2.3
|
25.9
|
1.0
|
HE
|
A:ARG516
|
2.5
|
38.9
|
1.0
|
HB3
|
A:PHE517
|
3.0
|
28.5
|
1.0
|
HA
|
A:SER228
|
3.1
|
23.9
|
1.0
|
N
|
A:LEU229
|
3.1
|
19.8
|
1.0
|
N
|
A:PHE517
|
3.2
|
21.6
|
1.0
|
HA
|
A:ARG516
|
3.2
|
25.0
|
1.0
|
HH21
|
A:ARG516
|
3.2
|
43.1
|
1.0
|
NE
|
A:ARG516
|
3.3
|
32.4
|
1.0
|
HB2
|
A:SER228
|
3.4
|
25.1
|
1.0
|
HB2
|
A:LEU229
|
3.4
|
21.3
|
1.0
|
HB3
|
A:ARG516
|
3.6
|
29.0
|
1.0
|
HG
|
A:LEU229
|
3.6
|
23.4
|
1.0
|
CB
|
A:PHE517
|
3.7
|
23.8
|
1.0
|
HB2
|
A:PHE517
|
3.8
|
28.5
|
1.0
|
O
|
A:LEU229
|
3.8
|
20.6
|
1.0
|
CA
|
A:SER228
|
3.8
|
19.9
|
1.0
|
HD11
|
A:ILE231
|
3.9
|
32.9
|
1.0
|
CA
|
A:ARG516
|
3.9
|
20.9
|
1.0
|
NH2
|
A:ARG516
|
3.9
|
35.9
|
1.0
|
CB
|
A:LEU229
|
4.0
|
17.8
|
1.0
|
HD2
|
A:ARG516
|
4.0
|
35.8
|
1.0
|
C
|
A:SER228
|
4.0
|
19.0
|
1.0
|
CA
|
A:LEU229
|
4.0
|
19.2
|
1.0
|
CB
|
A:SER228
|
4.0
|
20.9
|
1.0
|
CA
|
A:PHE517
|
4.0
|
22.4
|
1.0
|
C
|
A:ARG516
|
4.1
|
21.7
|
1.0
|
CZ
|
A:ARG516
|
4.1
|
33.5
|
1.0
|
CB
|
A:ARG516
|
4.2
|
24.2
|
1.0
|
CD
|
A:ARG516
|
4.2
|
29.8
|
1.0
|
CG
|
A:LEU229
|
4.2
|
19.5
|
1.0
|
HD12
|
A:LEU229
|
4.3
|
23.4
|
1.0
|
C
|
A:LEU229
|
4.4
|
18.6
|
1.0
|
HB3
|
A:SER228
|
4.4
|
25.1
|
1.0
|
O
|
A:PHE517
|
4.5
|
25.9
|
1.0
|
HD13
|
A:ILE231
|
4.5
|
32.9
|
1.0
|
CD1
|
A:ILE231
|
4.6
|
27.4
|
1.0
|
O
|
A:HOH733
|
4.7
|
32.0
|
1.0
|
HH22
|
A:ARG516
|
4.7
|
43.1
|
1.0
|
C
|
A:PHE517
|
4.8
|
23.6
|
1.0
|
CD1
|
A:LEU229
|
4.8
|
19.5
|
1.0
|
HA
|
A:PHE517
|
4.8
|
26.9
|
1.0
|
CG
|
A:ARG516
|
4.8
|
27.8
|
1.0
|
HB3
|
A:LEU229
|
4.9
|
21.3
|
1.0
|
HD2
|
A:PHE517
|
4.9
|
30.8
|
1.0
|
HA
|
A:LEU229
|
4.9
|
23.1
|
1.0
|
HB2
|
A:ARG516
|
5.0
|
29.0
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 5lkg
Go back to
Magnesium Binding Sites List in 5lkg
Magnesium binding site 2 out
of 2 in the Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with 2- Fucosyllactose (2'Fl) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg601
b:18.6
occ:1.00
|
H
|
B:LEU229
|
2.4
|
23.4
|
1.0
|
HE
|
B:ARG516
|
2.4
|
43.9
|
1.0
|
H
|
B:PHE517
|
2.4
|
26.0
|
1.0
|
HB3
|
B:PHE517
|
3.1
|
26.9
|
1.0
|
O
|
B:HOH927
|
3.1
|
45.5
|
1.0
|
HA
|
B:ARG516
|
3.2
|
27.1
|
1.0
|
N
|
B:LEU229
|
3.2
|
19.5
|
1.0
|
NE
|
B:ARG516
|
3.2
|
36.6
|
1.0
|
N
|
B:PHE517
|
3.3
|
21.6
|
1.0
|
HA
|
B:SER228
|
3.3
|
23.8
|
1.0
|
HH21
|
B:ARG516
|
3.3
|
49.1
|
1.0
|
HB2
|
B:LEU229
|
3.3
|
21.3
|
1.0
|
HB2
|
B:SER228
|
3.5
|
24.9
|
1.0
|
HG
|
B:LEU229
|
3.7
|
23.3
|
1.0
|
HB2
|
B:PHE517
|
3.7
|
26.9
|
1.0
|
CB
|
B:PHE517
|
3.8
|
22.4
|
1.0
|
O
|
B:LEU229
|
3.8
|
20.5
|
1.0
|
HD2
|
B:ARG516
|
3.8
|
40.2
|
1.0
|
HB3
|
B:ARG516
|
3.8
|
30.3
|
1.0
|
HD11
|
B:ILE231
|
3.9
|
36.1
|
1.0
|
CA
|
B:SER228
|
3.9
|
19.8
|
1.0
|
NH2
|
B:ARG516
|
3.9
|
41.0
|
1.0
|
CA
|
B:ARG516
|
4.0
|
22.6
|
1.0
|
CB
|
B:LEU229
|
4.0
|
17.7
|
1.0
|
CA
|
B:LEU229
|
4.1
|
18.7
|
1.0
|
CZ
|
B:ARG516
|
4.1
|
39.8
|
1.0
|
C
|
B:SER228
|
4.1
|
18.8
|
1.0
|
CD
|
B:ARG516
|
4.1
|
33.5
|
1.0
|
CA
|
B:PHE517
|
4.1
|
22.5
|
1.0
|
C
|
B:ARG516
|
4.1
|
22.6
|
1.0
|
CB
|
B:SER228
|
4.1
|
20.8
|
1.0
|
HD12
|
B:LEU229
|
4.2
|
25.0
|
1.0
|
CG
|
B:LEU229
|
4.3
|
19.4
|
1.0
|
CB
|
B:ARG516
|
4.3
|
25.2
|
1.0
|
HD13
|
B:ILE231
|
4.4
|
36.1
|
1.0
|
C
|
B:LEU229
|
4.4
|
18.7
|
1.0
|
HB3
|
B:SER228
|
4.5
|
24.9
|
1.0
|
CD1
|
B:ILE231
|
4.6
|
30.1
|
1.0
|
O
|
B:HOH726
|
4.6
|
33.8
|
1.0
|
O
|
B:PHE517
|
4.7
|
22.9
|
1.0
|
HH22
|
B:ARG516
|
4.7
|
49.1
|
1.0
|
O
|
B:HOH729
|
4.8
|
34.6
|
1.0
|
CD1
|
B:LEU229
|
4.8
|
20.8
|
1.0
|
HD12
|
B:ILE231
|
4.8
|
36.1
|
1.0
|
HB3
|
B:LEU229
|
4.8
|
21.3
|
1.0
|
HA
|
B:PHE517
|
4.8
|
26.9
|
1.0
|
CG
|
B:ARG516
|
4.9
|
29.2
|
1.0
|
HD3
|
B:ARG516
|
4.9
|
40.2
|
1.0
|
HD2
|
B:PHE517
|
4.9
|
30.4
|
1.0
|
HA
|
B:LEU229
|
4.9
|
22.5
|
1.0
|
C
|
B:PHE517
|
4.9
|
22.4
|
1.0
|
O
|
B:PHE515
|
5.0
|
21.0
|
1.0
|
|
Reference:
A.Koromyslova,
S.Tripathi,
V.Morozov,
H.Schroten,
G.S.Hansman.
Human Norovirus Inhibition By A Human Milk Oligosaccharide. Virology V. 508 81 2017.
ISSN: ISSN 1096-0341
PubMed: 28505592
DOI: 10.1016/J.VIROL.2017.04.032
Page generated: Sun Sep 29 20:15:08 2024
|